Resilience Therapeutics, Inc. — Form D/A
Resilience Therapeutics, Inc. of DUXBURY, MA, a company, filed a Form D amendment with the SEC on 2015-06-30. The offering totals $3.0M, of which $2.7M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2015-06-30
- Form: D/A
- Accession: 0001630938-15-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $2.7M
- Remaining: $285K
- Investors: 29
- Date of first sale: 2015-01-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-232603
Issuer
- Name: Resilience Therapeutics, Inc.
- CIK: 0001630938
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 536 BAY ROAD, DUXBURY, MA, 02332
- Phone: 617-780-2375
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Restina M Meyer | Executive Officer | Duxbury, MA |
| Jason E Fuller | Director | DUXBURY, MA |
| Jeffrey R Sabados | Director | DUXBURY, MA |
| Jeffrey R Sabados | Executive Officer | DUXBURY, MA |
| William M Cowan | Director | DUXBURY, MA |
| Retsina M Meyer | Executive Officer | Duxbury, MA |
Other filings by this issuer (4)
More